Patents by Inventor Xiazhen WEI

Xiazhen WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition of sea buckthorn pulp oil and panax notoginseng saponins for treating osteoporotic fracture and/or osteoarthritis and uses thereof
    Patent number: 10758580
    Abstract: The present disclosure discloses a natural pharmaceutical composition for treating osteoporotic fracture and/or osteoarthritis and an application thereof. The composition is composed of 73.3 wt %-98.3 wt % of sea buckthorn pulp oil and 1.7 wt %-26.7 wt % of panax notoginseng saponins. The composition can be further used for preventing and treating ostealgia diseases.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: September 1, 2020
    Assignee: SHAANXI TIANKUI BIOMEDICINE TECHNOLOGY LIMITED COMPANY
    Inventors: Xiazhen Wei, Lanlan Song, Shaohua Han
  • NATURAL PHARMACEUTICAL COMPOSITION FOR TREATING MENOPAUSAL MENTAL DEPRESSION AND ATYPICAL DEPRESSIVE DISORDER AND APPLICATION THEREOF
    Publication number: 20180161383
    Abstract: The present disclosure discloses a pharmaceutical composition for treating menopausal mental depression and atypical depressive disorder and an application thereof. The composition is composed of the following components in percentage by mass: 70%-97.5% of sea buckthorn pulp oil and 2.5%-30% of total panax notoginseng saponins from stem and leave. The application is use of the pharmaceutical composition for preparing drugs and/or health care products used for treating menopause, the menopausal mental depression or the atypical depressive disorder.
    Type: Application
    Filed: January 12, 2018
    Publication date: June 14, 2018
    Inventors: Xiazhen WEI, Lanlan SONG, Shaohua HAN
  • NATURAL PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROTIC FRACTURE AND/OR OSTEOARTHRITIS AND USE THEREOF
    Publication number: 20180125907
    Abstract: The present disclosure discloses a natural pharmaceutical composition for treating osteoporotic fracture and/or osteoarthritis and an application thereof. The composition is composed of 73.3 wt %-98.3 wt % of sea buckthorn pulp oil and 1.7 wt %-26.7 wt % of panax notoginseng saponins. The composition can be further used for preventing and treating ostealgia diseases.
    Type: Application
    Filed: January 5, 2018
    Publication date: May 10, 2018
    Inventors: Xiazhen WEI, Lanlan SONG, Shaohua HAN